As of September 2024 Syncom Formulations has 928.53M shares outstanding, a increase of 13.67% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 928.53M | 13.67% |
2022 | 816.85M | 4.62% |
2021 | 780.75M | -6.88% |
2020 | 838.44M | - |